Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

• Status: Completed
• Trial end date: 2011-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to explore if the combination of vinorelbine and gemcitabine is better than vinorelbine and carboplatin in the treatment of advanced non-small cell lung cancer, in terms of survival, quality of life and need for palliative radiotherapy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Norwegian Lung Cancer Study Group
• Treatments: Carboplatin; Gemcitabine; Vinblastine; Vinorelbine

Criteria

Inclusion Criteria:

• Non-small cell lung cancer stage IIIB or IV

• Not eligible for radical radiotherapy or surgery

• WHO performance status 0-2

Exclusion Criteria:

• Pregnancy

• Other clinical active cancer disease

• ALAT/ALP more than 3 times upper normal limit, bilirubin >1.5 upper limit

• Bowel disease that causes malabsorption